The latest price target for Diversified Healthcare (NASDAQ:DHC) was reported by B. Riley Securities on December 15, 2025. The analyst firm set a price target for $6.50 expecting DHC to rise to within 12 months (a possible 32.38% upside). 3 analyst firms have reported ratings in the last year.

The latest analyst rating for Diversified Healthcare (NASDAQ:DHC) was provided by B. Riley Securities, and Diversified Healthcare reiterated their buy rating.

The last upgrade for Diversified Healthcare Trust happened on November 13, 2025 when RBC Capital raised their price target to $5. RBC Capital previously had an underperform for Diversified Healthcare Trust.

There is no last downgrade for Diversified Healthcare.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Diversified Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Diversified Healthcare was filed on December 15, 2025 so you should expect the next rating to be made available sometime around December 15, 2026.

While ratings are subjective and will change, the latest Diversified Healthcare (DHC) rating was a reiterated with a price target of $5.50 to $6.50. The current price Diversified Healthcare (DHC) is trading at is $4.91, which is out of the analyst’s predicted range.